Ponesimod
Back to searchMolecule Structure
Scientific Name
Ponesimod
Description of the Drug
Ponesimod is a sphingosine 1-phosphate receptor modulator indicated to treat relapsing multiple sclerosis.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB12016
http://www.drugbank.ca/drugs/DB12016
Brand Name(s)
Ponvory
Company Owner(s)
Janssen Pharmaceuticals Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Sphingosine 1-phosphate receptor Edg-1 | SINGLE PROTEIN | AGONIST | CHEMBL4333 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL15477934 |
| DrugBank | DB12016 |
| PubChem: Thomson Pharma | 16455635 |
| BindingDB | 50316768 |
| EPA CompTox Dashboard | DTXSID50234631 |
| ChemicalBook | CB22598855 |
| ZINC | ZINC000034509627 |
